Characteristics of the 78 patients with acute myeloid leukemia (AML) receiving dynamic contrast-enhanced magnetic resonance image (DCE-MRI)
Variable . | No. of patients (%) . |
---|---|
Male | 37 (47) |
Female | 41 (53) |
Age, y* | 49 (17-76) |
FAB classification* | |
M0 | 1 (1.3) |
M1 | 16 (20.5) |
M2 | 31 (39.8) |
M3 | 5 (6.4) |
M4 | 16 (20.5) |
M5 | 4 (5.1) |
M6 | 4 (5.1) |
Unclassified | 1 (1.3) |
Karyotype† | |
Favorable | 14 (18.0) |
Intermediate | 52 (66.7) |
Unfavorable | 10 (12.8) |
Unknown | 2 (2.5) |
Follow-up, mo* | 16.2 (4-34.3) |
CR | 57 (73.1) |
CR duration, mo* | 9.0 (1-33.4) |
Overall survival, mo* | 11.3 (0.4-34.3) |
Variable . | No. of patients (%) . |
---|---|
Male | 37 (47) |
Female | 41 (53) |
Age, y* | 49 (17-76) |
FAB classification* | |
M0 | 1 (1.3) |
M1 | 16 (20.5) |
M2 | 31 (39.8) |
M3 | 5 (6.4) |
M4 | 16 (20.5) |
M5 | 4 (5.1) |
M6 | 4 (5.1) |
Unclassified | 1 (1.3) |
Karyotype† | |
Favorable | 14 (18.0) |
Intermediate | 52 (66.7) |
Unfavorable | 10 (12.8) |
Unknown | 2 (2.5) |
Follow-up, mo* | 16.2 (4-34.3) |
CR | 57 (73.1) |
CR duration, mo* | 9.0 (1-33.4) |
Overall survival, mo* | 11.3 (0.4-34.3) |